Company / R&D per Share
Relay Therapeutics, Inc. R&D per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.56
FY2025
5-year range
$0.78 / $2.72
FY2021-FY2025
Trend
-37.8%
vs FY2024
Sector context
#121 of 208
Health Care
What the data says
At $1.56, Relay Therapeutics, Inc.'s r&d per share ranks #121 of 208 in the Health Care sector. Declined from $2.72 to $1.56 over the past 2 years.
Based on SEC 10-K filings.
1.56 in FY2025 with a 5-year CAGR of -38.3%.
Declined from $2.72 to $1.56 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +19.1%
- 5-Year CAGR
- -38.3%
- 10-Year CAGR
- -
Sector benchmark
#121 of 208 in Health CareTop 58% of 208This company $1.56 Sector average $12.19
▼
-87.2% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 37.8% year-over-year.
- Ranks #121 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.79 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.56 | -37.8% |
| FY2024 | $2.50 | -8.1% |
| FY2023 | $2.72 | +195.3% |
| FY2022 | $0.92 | +18.0% |
| FY2021 | $0.78 | -95.5% |
| FY2020 | $17.41 | -14.5% |
| FY2019 | $20.38 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026